Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S McDowell

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Drug Discovery Today|June 25, 2003
Discovery of small molecule leads in a biotechnology datastreamThomas R Gadek, Robert S McDowell
Journal of Medicinal Chemistry|June 25, 2004
Fragment-based drug discoveryDaniel A Erlanson, Robert S McDowell, Tom O'Brien
Structure (London, England : 1993)|August 7, 2004
Crystal structures of a ligand-free and malonate-bound human caspase-1: implications for the mechanism of substrate bindingMichael J Romanowski, Justin M Scheer, Tom O'Brien, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
N-Benzoyl amino acids as ICAM/LFA-1 inhibitors. Part 2: structure-activity relationship of the benzoyl moietyDaniel J Burdick, James C Marsters, Ignacio Aliagas-Martin, et al.
Journal of the American Chemical Society|May 8, 2003
Discovery of a new phosphotyrosine mimetic for PTP1B using breakaway tetheringDaniel A Erlanson, Robert S McDowell, Molly M He, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
N-Benzoyl amino acids as LFA-1/ICAM inhibitors 1: amino acid structure-activity relationshipDaniel J Burdick, Ken Paris, Kenneth Weese, et al.
Journal of the American Chemical Society|March 27, 2003
Discovery of a potent small molecule IL-2 inhibitor through fragment assemblyAndrew C Braisted, Johan D Oslob, Warren L Delano, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Identification of nonpeptidic small-molecule inhibitors of interleukin-2Nathan D Waal, Wenjin Yang, Johan D Oslob, et al.
Journal of Medicinal Chemistry|May 28, 2004
Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: an approach for inhibiting protein-protein interactionsBrian C Raimundo, Johan D Oslob, Andrew C Braisted, et al.
Plos One|April 27, 2010
Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase IIRachael E Hawtin, David E Stockett, Jo Ann W Byl, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Drug Discovery Today|June 25, 2003
Discovery of small molecule leads in a biotechnology datastreamThomas R Gadek, Robert S McDowell
Journal of Medicinal Chemistry|June 25, 2004
Fragment-based drug discoveryDaniel A Erlanson, Robert S McDowell, Tom O'Brien
Structure (London, England : 1993)|August 7, 2004
Crystal structures of a ligand-free and malonate-bound human caspase-1: implications for the mechanism of substrate bindingMichael J Romanowski, Justin M Scheer, Tom O'Brien, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
N-Benzoyl amino acids as ICAM/LFA-1 inhibitors. Part 2: structure-activity relationship of the benzoyl moietyDaniel J Burdick, James C Marsters, Ignacio Aliagas-Martin, et al.
Journal of the American Chemical Society|May 8, 2003
Discovery of a new phosphotyrosine mimetic for PTP1B using breakaway tetheringDaniel A Erlanson, Robert S McDowell, Molly M He, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
N-Benzoyl amino acids as LFA-1/ICAM inhibitors 1: amino acid structure-activity relationshipDaniel J Burdick, Ken Paris, Kenneth Weese, et al.
Journal of the American Chemical Society|March 27, 2003
Discovery of a potent small molecule IL-2 inhibitor through fragment assemblyAndrew C Braisted, Johan D Oslob, Warren L Delano, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Identification of nonpeptidic small-molecule inhibitors of interleukin-2Nathan D Waal, Wenjin Yang, Johan D Oslob, et al.
Journal of Medicinal Chemistry|May 28, 2004
Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: an approach for inhibiting protein-protein interactionsBrian C Raimundo, Johan D Oslob, Andrew C Braisted, et al.
Plos One|April 27, 2010
Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase IIRachael E Hawtin, David E Stockett, Jo Ann W Byl, et al.
Pageof 3